Astrazeneca Plc ADR (AZN)

Jan 17, 2025, 5:35 PM EST - 6 hours ago

DATROWAY® Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer

Jan 17, 2025, 1:30 PM EST - 10 hours ago

US FDA approves AstraZeneca's drug for breast cancer

Jan 17, 2025, 11:15 AM EST - 13 hours ago

The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against AstraZeneca PLC

Jan 17, 2025, 9:12 AM EST - 15 hours ago

AstraZeneca overhauls management of its China division, FT reports

Jan 17, 2025, 7:00 AM EST - 17 hours ago

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma

Jan 16, 2025, 10:45 AM EST - 1 day ago

AstraZeneca PLC Is Being Sued For Securities Law Violations And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Jan 15, 2025, 2:13 PM EST - 2 days ago

AstraZeneca (AZN) Reels from China Investigation and Investor Suit–Hagens Berman

Jan 15, 2025, 12:46 PM EST - 2 days ago

AstraZeneca PLC Sued for Securities Law Violations - Contact The Gross Law Firm Before February 21, 2025 to Discuss Your Rights – AZN

Jan 15, 2025, 11:43 AM EST - 2 days ago

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Jan 14, 2025, 12:54 PM EST - 3 days ago

Josh Brown's 'best stocks in the market'

ANET BDX EOG MMM

Jan 14, 2025, 12:53 PM EST - 3 days ago

Trade Tracker: Jim Lebenthal buys Astrazeneca

Jan 14, 2025, 11:15 AM EST - 3 days ago

AstraZeneca PLC Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

Jan 13, 2025, 6:55 PM EST - 4 days ago

AstraZeneca PLC Investors: Please contact the Portnoy Law Firm to recover your losses. February 21, 2025 Deadline to file Lead Plaintiff Motion

Jan 13, 2025, 6:10 PM EST - 4 days ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN BNTX FBCG GILD GSK IBB

Jan 13, 2025, 10:40 AM EST - 4 days ago

AstraZeneca (AZN) Reels from China Investigation and Investor Suit – Hagens Berman

Jan 13, 2025, 7:00 AM EST - 4 days ago

Datopotamab deruxtecan granted Priority Review in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer

Jan 13, 2025, 2:00 AM EST - 4 days ago

Datopotamab Deruxtecan Granted Priority Review in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Jan 8, 2025, 12:45 PM EST - 9 days ago

AstraZeneca (AZN) Reels from China Investigation and Investor Suit - Hagens Berman

Jan 8, 2025, 2:20 AM EST - 9 days ago

BioInvent Announces Promising Initial Efficacy Data from Triple Combination Arm of BI-1206, Rituximab and Calquence for the Treatment of non-Hodgkin's Lymphoma

Jan 7, 2025, 8:03 PM EST - 10 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Jan 7, 2025, 7:00 PM EST - 10 days ago

AstraZeneca (AZN) Reels from China Investigation and Investor Suit– Hagens Berman

Jan 7, 2025, 2:57 PM EST - 10 days ago

Deadline Approaching: AstraZeneca PLC (AZN) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Jan 7, 2025, 12:32 PM EST - 10 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca PLC Lawsuit – AZN

Jan 7, 2025, 12:30 PM EST - 10 days ago

Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against AstraZeneca PLC

Jan 7, 2025, 8:10 AM EST - 10 days ago

J&J's combo extends patients' lives in head-to-head study with AstraZeneca's drug

JNJ

Jan 7, 2025, 8:00 AM EST - 10 days ago

Asher Bio Announces Clinical Supply Agreement to Enable Evaluation of Etakafusp Alfa (AB248) in Combination with Rilvegostomig in a Global Phase 1b/2 Study in Non-Small Cell Lung Cancer (NSCLC)

Jan 6, 2025, 11:15 AM EST - 11 days ago

AstraZeneca PLC Is Being Sued For Securities Law Violations And The Schall Law Firm Urges Impacted Shareholders To Reach Out

Jan 6, 2025, 11:05 AM EST - 11 days ago

The Law Offices of Frank R. Cruz Continues Its Investigation of AstraZeneca PLC (AZN) on Behalf of Investors

Jan 5, 2025, 11:30 AM EST - 12 days ago

Investors With Losses Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against AstraZeneca PLC

Jan 4, 2025, 11:15 AM EST - 13 days ago

AstraZeneca PLC Is Being Sued For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out

Jan 3, 2025, 11:30 AM EST - 14 days ago

Investors With Losses Are Invited To Join A Securities Fraud Case Against AstraZeneca PLC

Jan 2, 2025, 10:42 AM EST - 15 days ago

AstraZeneca PLC Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AZN

Dec 24, 2024, 12:07 PM EST - 24 days ago

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against AstraZeneca PLC (AZN)

Dec 24, 2024, 3:09 AM EST - 24 days ago

AstraZeneca withdraws application for lung cancer drug in EU

Dec 24, 2024, 2:00 AM EST - 24 days ago

Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn

Dec 23, 2024, 5:01 PM EST - 25 days ago

AstraZeneca PLC Investors: Please contact the Portnoy Law Firm to recover your losses; February 21, 2025 Deadline to file Lead Plaintiff Motion